Skip to main content Deutsch

Detail

Lucian Beer
PD. Dr. Lucian Beer, PhDConsultant Radiologist

Department of Biomedical Imaging and Image-guided Therapy
Position: Consultant

ORCID: 0000-0003-4388-7580
T +43 1 40400 48180
lucian.beer@meduniwien.ac.at

Keywords

Carcinoma, Non-Small-Cell Lung; Diagnostic Imaging; Liver Cirrhosis; Multidetector Computed Tomography

Research interests

  • Oncologic Imaging: non small cell lung cancer, high grade serous ovarian cancer
  • Hepatobiliary Imaging
  • Advanced imaging techniques: hyperpolarized MRI

Techniques, methods & infrastructure

  • Translational research in oncologic imaging
  • Functional imaging and 18F FDG-PET/CT
  • Hepatobiliary Imaging using liver-specific contrast agents
  • Hyperpolarized MRI

Grants

  • Multiparametric PET/MRI-based response evaluation in patients with lung cancer receiving immune checkpoint inhibitors (2016)
    Source of Funding: City of Vienna, Diagnostic Imaging
    Principal Investigator
  • Stellenwert der Perfusions-Computertomographie in der onkologischen Bildgebung. (2016)
    Source of Funding: OeNB (Oesterreichische Nationalbank), Radiologie
    Principal Investigator

Selected publications

  1. Bastati, N. & Beer, L. et al. (2022) ‘Gadoxetic acid-enhanced MRI-derived functional liver imaging score (FLIS) and spleen diameter predict outcomes in ACLD’, Journal of Hepatology, 77(4), pp. 1005–1013. Available at: http://dx.doi.org/10.1016/j.jhep.2022.04.032.
  2. Beer, L. et al. (2020) ‘Ultrasound-guided targeted biopsies of CT-based radiomic tumour habitats: technical development and initial experience in metastatic ovarian cancer’, European Radiology, 31(6), pp. 3765–3772. Available at: http://dx.doi.org/10.1007/s00330-020-07560-8.
  3. Beer, L. et al. (2020) ‘Ultrasound-guided targeted biopsies of CT-based radiomic tumour habitats: technical development and initial experience in metastatic ovarian cancer’, European Radiology, 31(6), pp. 3765–3772. Available at: http://dx.doi.org/10.1007/s00330-020-07560-8.
  4. Beer, L. et al. (2019) ‘Comparison of RECIST, iRECIST, and PERCIST for the Evaluation of Response to PD-1/PD-L1 Blockade Therapy in Patients With Non–Small Cell Lung Cancer’, Clinical Nuclear Medicine, 44(7), pp. 535–543. Available at: http://dx.doi.org/10.1097/rlu.0000000000002603.
  5. Beer, L. et al. (2015) ‘Analysis of the Secretome of Apoptotic Peripheral Blood Mononuclear Cells: Impact of Released Proteins and Exosomes for Tissue Regeneration’, Scientific Reports, 5(1). Available at: http://dx.doi.org/10.1038/srep16662.